These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4093187)

  • 21. Population screening for cervical carcinoma in Frederiksberg borough: economic considerations.
    Gad C; Ostergaard E
    Dan Med Bull; 1977 Apr; 24(2):60-5. PubMed ID: 852314
    [No Abstract]   [Full Text] [Related]  

  • 22. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 23. [Differences in cervical cancer mass screening results in Greater-Helsinki area].
    Nieminen P; Tarkkanen J; Timonen T; Meyer B; Hakama M; Anttila A
    Duodecim; 2000; 116(22):2489-96. PubMed ID: 12053343
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cervix neoplasms and mass screening].
    Hakama M
    Duodecim; 1970; 86(9):528-35. PubMed ID: 5463389
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of screening for cervix carcinoma].
    Gaasbeek Janzen HM; Gimbrère CH; Eliel MR
    Ned Tijdschr Geneeskd; 1993 Jan; 137(5):266-7. PubMed ID: 8433767
    [No Abstract]   [Full Text] [Related]  

  • 26. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries.
    Engeland A; Haldorsen T; Tretli S; Hakulinen T; Hörte LG; Luostarinen T; Schou G; Sigvaldason H; Storm HH; Tulinius H
    APMIS Suppl; 1995; 49():1-161. PubMed ID: 7702878
    [No Abstract]   [Full Text] [Related]  

  • 27. [Mass screening for cervical cancer. A one-year registration of cervical cytological tests].
    Bjørge T; Gunbjørud AB; Langmark F; Skare GB; Thoresen SO
    Tidsskr Nor Laegeforen; 1994 Jan; 114(3):341-5. PubMed ID: 8191435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity in cancer rates, control programs matches diversity of European Union.
    Zielinski SL
    J Natl Cancer Inst; 2005 Oct; 97(19):1398-9. PubMed ID: 16204685
    [No Abstract]   [Full Text] [Related]  

  • 29. Resources and productivity in radiation oncology in Denmark, Finland, Iceland, Norway and Sweden during 1987.
    Lote K; Möller T; Nordman E; Overgaard J; Sveinsson T
    Acta Oncol; 1991; 30(5):555-61. PubMed ID: 1909879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a pilot study for breast and cervical cancer screening with Bradford's minority ethnic women; a community development approach, 1991-93.
    Kernohan EE
    Br J Cancer Suppl; 1996 Sep; 29():S42-6. PubMed ID: 8782798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 32. Avoidable cancers in the Nordic countries. Aims and background.
    Olsen JH
    APMIS Suppl; 1997; 76():1-8. PubMed ID: 9462817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Standardized incidence rates of total hip replacement for primary hip osteoarthritis in the 5 Nordic countries: similarities and differences.
    Lohmander LS; Engesaeter LB; Herberts P; Ingvarsson T; Lucht U; Puolakka TJ
    Acta Orthop; 2006 Oct; 77(5):733-40. PubMed ID: 17068703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prediction of cancer incidence in Finland for the year 1980 by means of cancer registry material.
    Teppo L; Hakulinen T; Saxén E
    Ann Clin Res; 1974 Apr; 6(2):122-5. PubMed ID: 4837884
    [No Abstract]   [Full Text] [Related]  

  • 36. [Gynecologic health screening in Canada and Sweden].
    Rubinstein E
    Lakartidningen; 1979 Mar; 76(12):1083-4. PubMed ID: 431202
    [No Abstract]   [Full Text] [Related]  

  • 37. Routine audit of large-scale cervical cancer screening programs.
    Cuzick J
    J Natl Cancer Inst; 2008 May; 100(9):605-6. PubMed ID: 18445817
    [No Abstract]   [Full Text] [Related]  

  • 38. Studs on population screening for early carcinoma of the uterine cervix.
    Bjerre B
    Acta Obstet Gynecol Scand Suppl; 1969; 6():1-140. PubMed ID: 5266058
    [No Abstract]   [Full Text] [Related]  

  • 39. Proceedings: Cooperative clinical trials in primary breast cancer: a critical appraisal.
    Fisher B
    Proc Natl Cancer Conf; 1972; 7():285-302. PubMed ID: 4587648
    [No Abstract]   [Full Text] [Related]  

  • 40. [The general criteria and recommendations for the elaboration of programs for the early detection of breast cancer and cervical cancer in Spain. The Working Group for the Early Detection of Breast Cancer and Cervical Cancer].
    Ascunze Elizaga N; González Enríquez J; González Navarro A; Herranz Fernández C; Marqués Bravo A; Martín Pérez J
    Rev Sanid Hig Publica (Madr); 1993; 67(1):23-37. PubMed ID: 7725048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.